Screen Reader Mode Icon

Question Title

* 1. Please provide your name and business information.

Question Title

* 2. Who conducted your training?   (name of instructor)

Question Title

* 3. When did your training occur?

Date

Question Title

* 4. Please enter the proforma # from your product purchase for this training.

Question Title

* 5. Prior to your PACE trainers in-person training, were you contacted and given adequate preparation and communication for your in-service session?

(i.e. supplies needed, patient model selection, goals and objectives for this session, time block needed)

Question Title

* 6. During the in-service session, did your PACE trainer review the science of Prollenium products, as well as the FDA cleared indications?

Question Title

* 7. Which area(s) where you trained on using Revanesse?

Question Title

* 8. The length of this dermal filler training course was appropriate.

Question Title

* 9. How would you rate your overall experience while attending this dermal filler training course?

Question Title

* 10. Would you recommend this dermal filler training course to other injectors?

Question Title

* 11. All topics were relevant to me and my responsibilities within my clinic.

Question Title

* 12. The depth and quality of information provided was sufficient.

Question Title

* 13. The patient assessments, hands-on injection experience and observation were educational and helped me to gain confidence with injecting dermal fillers.

Question Title

* 14. I believe participating in this dermal filler training will make me more successful in my current role?

Question Title

* 15. The trainer was knowledgeable and engaging.

Question Title

* 16. The overall teaching style was conducive to my learning style.

Question Title

* 17. What were the most beneficial aspects of this dermal filler training course?

Question Title

* 18. What topics or activities would you have liked to spend more time on?

Question Title

* 19. What aspects of this course could be improved?

Question Title

* 20. Please add any additional comments you would like to share with us.

0 of 20 answered
 

T